Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the record history, and the previous revision v3.6.6 has been removed.
    Difference
    0.1%
    Check dated 2026-09-16T00:31:25.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The header of the Record History page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor frontend/backend update to the history view without altering the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-01T20:30:08.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 appears in the study's history with a Study Status update. This indicates the record has been revised and the trial's status has been updated within the official history.
    Difference
    0.3%
    Check dated 2026-08-11T17:56:44.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The record history shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a small update to the page framework without impacting trial details.
    Difference
    0.1%
    Check dated 2026-07-21T12:52:46.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.3) was added to the history and the older tag (v3.6.0) was removed, reflecting an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-30T02:15:28.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    A new revision (v3.6.0) adds a note that the study is no longer looking for participants. The previous revision label (v3.5.5) is removed from the history.
    Difference
    0.3%
    Check dated 2026-06-15T19:46:37.000Z thumbnail image

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.